1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow CAR-T Cell: new trials by email Literature Review of CAR-T Cell trials Research Report on CAR-T Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dasatinib Plus Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for Elderly Ph-positive ALL Patients Dasatinib plus anti-CD19/CD22 CAR-T cells - Ph Positive ALL, CAR-T Cell | Phase 1 | Unknown | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 15 | 2021-03-01 | 2023-11-28 |
Dasatinib (1)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)
China (1)